Our team at JosephCareRX understands that successful weight loss involves more than just medication
These lifestyle behaviors a cornerstone of the WeightWatchers Program are one reason why members who discontinued GLP-1 medication not only maintained their weight loss, but dropped an additional 1.8% of their body weight after 13 weeks.* Also, make sure you time it right
While Semaglutide is more widely used for significant weight loss, Liraglutide may be better suited for certain individuals based on their health profile
Lifestyle intervention in patients with obesity and type 2 diabetes
GLP-1-RA such as liraglutide [4], semaglutide [5], and the dual agonist tirzepatide [6], activating both the GLP1- and the gastric-inhibitory polypeptide receptor (GIP-R), have been shown to significantly reduce body weight, making them a promising therapeutic option for the treatment of obesity
Having more options available to patients is a good thing, says Daniel Drucker, an endocrinologist at the University of Toronto whose research paved the way for GLP-1 drugs but who was not involved in the new studies